The largest database of trusted experimental protocols

6 well plate

Manufactured by BD
Sourced in United States, United Kingdom, Germany, Belgium, Japan, China

The 6-well plates are a type of cell culture vessel used for in vitro experiments. Each plate has six individual wells, providing a standardized platform for culturing and studying cells. The plates are designed to maintain a controlled environment for cell growth and analysis.

Automatically generated - may contain errors

299 protocols using 6 well plate

1

Paracrine Factors in MSC Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
To test the role of RPTEC-derived paracrine factors in MSC differentiation, MSCs were seeded in MSCBM, at a density of 50,000 cells/well in 6-well plates (Becton Dickinson) and stimulated with 150,000 EVs/cell, 30% CM, or 30% TOT-CM for 7–14 days before RNA extraction. When using TOT-CM to stimulate MSCs, we maintained the same ratio EV:cells that we used to stimulate MSCs with EVs. For co-culture experiments, a transwell system with a 1 μm pore size permeable membrane (Becton Dickinson) was used to separate RPTECs physically from bone marrow MSCs in 6-well plates (Becton Dickinson). RPTECs were seeded into the upper insert of the transwell system in DMEM with 5% FBS, at a density of 100,000 cells/well. MSCs were seeded into the lower chamber of this co-culture system, at a density of 50,000 cells/well. MSCs cultured alone in MSCBM were used as control. Cells were maintained in co-culture conditions for 7 days before RNA extraction. Six different experiments with similar results were done.
+ Open protocol
+ Expand
2

Protein-Functionalized Micropattern Arrays

Check if the same lab product or an alternative is used in the 5 most similar protocols
6-well plates (Falcon) were first coated with a mixture of recombinant protein G (4 µg/cm2) (Invitrogen) and human fibronectin (4 µg/cm2) (Corning) diluted in PBS over night (o/n) at room temperature (RT). Unbound proteins were removed by washing the plates three times with PBS, followed by blocking with 1% (w/v) BSA in PBS at RT for 1 hour. Wells were incubated for 4 h at RT with recombinant Fc-tagged Notch ligand proteins Dll1 (Adipogen Life Science), Jagged1 and Jagged2 (R&D) or antibodies against the β2 microglobulin (β2MG) subunit of the human major histocompatibility complex (Abcam) (2.5 µg/cm2), diluted in 0.1% (w/v) BSA in Hanks Buffered Salt Solution (HBSS). Any protein not bound to protein G was removed by washing the substrates three times with HBSS. Glass microchips containing micropatterned arrays of 20 μm and 50 μm circular islands were placed into 6-well plates (Falcon) and functionalised as described above. Functionalised substrates were prepared fresh for each experiment and kept in HBSS until use.
+ Open protocol
+ Expand
3

Co-Culture Assay for Angiogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
HUVECs were seeded in 6-well plates (Falcon) in MCDB131 complete medium, and after 6h they were deprived of nutrients/hormones with restricted medium (RM) consisting of DMEM with 5.56 mM glucose (Sigma) supplemented with 2% FBS, 2 mM glutamine and 0.1% streptomycin/penicillin, overnight. Simultaneously, PC-3M and PC-3S cells were seeded in cell culture inserts supported in separate 6-well plates (Falcon) in RPMI complete medium. After 24h all the cells were washed with PBS and RM was added to both HUVECs and PC-3M and PC-3S cells, and inserts placed over the wells for the co-culture incubation. For the VEGF condition, HUVECs were maintained in the 6-well plates in RM supplemented with 30 ng/mL of Human vascular endothelial growth factor 165 (VEGF165, Miltenyi Biotec) and control HUVECs were maintained only with the RM. Following a 24h incubation of the control and the experimental conditions under normoxia (21% O2, 5% CO2) at 37°C in a humidified atmosphere, the HUVECs in the wells (n = 3 biological replicates) were trypsinized and the pellets stored at -80°C until extraction.
+ Open protocol
+ Expand
4

Osteoclastogenesis from RAW264 and MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAW264 cells were seeded in 24-well plates (Falcon) at 5 × 10 3 cells/well. On the following day (day 0), RANK Ligand, Soluble, Murine, Recombinant (sRANKL; Pepro Tech, Rocky Hill, CT, USA) was added to α-MEM (Sigma Aldrich) at 100 ng/mL. The medium was replaced with medium containing sRANKL every 2nd day. On day 8, TRAP staining was performed using a TRAP/ALP staining kit (Wako, Tokyo, Japan) to confirm differentiation into osteoclasts, and cells were observed with a DMi1 microscope (Leica, Wetzlar, Germany).
Next, MSCs were seeded into 6-well plates (Falcon) at 1 × 10 4 cells/well, and RAW264 cells were seeded at In other 6-well plates (Falcon), RAW264 cells were cultured alone at 5 × 10 3 cells/well. On the following day (day 0), the culture medium was replaced with medium containing sRANKL (Pepro Tech) (sRANKL was added to both RAW264 only cultures and RAW264/MSC co-cultures), and the medium was replaced with fresh medium every 2nd day.
From day 0 (at the start of sRANKL addition), using the number of actin ring-forming cells with five or more nuclei to represent the number of mature osteoclasts, osteoclast counts among RAW264 cells cultured alone and in RAW264 cell/MSC co-cultures were compared.
+ Open protocol
+ Expand
5

Transfection of hWJCs with pDendra2

Check if the same lab product or an alternative is used in the 5 most similar protocols
On the day of transfection, medium from all wells was removed, and cells were washed with phosphate buffered saline (PBS) twice. Afterward, cells were incubated for 1 h at 37°C in traditional hWJC medium with 10 μM of Y-27632-ROCK Inhibitor (Reagents Direct, Encinitas, CA). After 1 h, hWJCs were washed twice with PBS, trypsinized, and then resuspended in either 100 μL 4D Nucleofector™ P1 Primary Solution (P1PS) (Lonza, Basel, Switzerland) (Untreated Control) or 95 μL of P1PS and 5 μL of pDendra2 (1 μg per μL; Clontech). Cells were resuspended at a density of 5×105 cells per 100 μL. Untreated control cells were immediately transferred to 6-well plates (BD Biosciences) containing 1.5 mL traditional hWJC medium and incubated at 37°C. hWJC suspensions containing pDendra2 were immediately transferred to 100-μL 4D Nucleofection™ cuvettes. Each cuvette was gently tapped twice then placed in a 4D Nucleofector™ (Lonza) and nucleofected with the program FF-104. hWJCs were incubated at room temperature (ca. 22°C) for 10 minutes then transferred to a 6-well plate (BD Biosciences) containing 1.5 mL traditional hWJC medium with 10 μM of Y-27632-RI (Reagents Direct) and incubated at 37 °C.
+ Open protocol
+ Expand
6

hBSMC Culture and PGD2 Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human BSM cells (hBSMCs; Cambrex Bio Sience Walkersville,
Inc., Walkersville, MD, USA) were maintained in SmBM medium supplemented with 5%
fetal bovine serum, 0.5 ng/ml human epidermal growth factor (hEGF), 5 µg/ml
insulin, 2 ng/ml human fibroblast growth factor-basic (hFGF-b), 50 µg/ml
gentamicin and 50 ng/ml amphotericin B. Cells were maintained at 37 °C in a
humidified atmosphere (5% CO2), fed every 48–72 h, and passaged when
cells reached 90–95% confluence. Then the hBSMCs (passages 4–7) were seeded in
6-well plates (Becton Dickinson Labware, Franklin Lakes, NJ, USA) at density of
3,500 cells/cm2 and, when 80–85% confluence was observed, cells were
cultured without serum for 24 h before the addition of PGD2. At the
indicated time after the treatment with PGD2, hBSMCs were immediately
collected and disrupted with 1× SDS sample buffer (150 µl/well), and used for
Western blot analyses.
+ Open protocol
+ Expand
7

Astrocyte Conditioned Medium Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The mesencephalic or striatal astrocytes were plated onto 6-well plates (Becton Dickinson) and grown in DMEM containing 10% FBS for 13 days. To prepare each astrocyte conditioned medium, each group of astrocytes was treated with 100 µM 6-OHDA (mesencephalic-6-OHDA-GCM, striatal-6-OHDA-GCM) or vehicle (mesencephalic-GCM, striatal-GCM) for 24 h. Then, each GCM and 6-OHDA-GCM were collected, centrifuged at 1500 rpm for 3 min to remove cellular debris, and the supernatants stored at −80 °C until use.
+ Open protocol
+ Expand
8

Mitochondrial tRNA Delivery Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded on 6-well plates (Becton Dickinson [Corning], Franklin Lakes, NJ, USA), 24 h prior to the experiment (2 mL, 1 × 105 cells/mL, incubation at 37°C, 5% CO2). After washing the cells with 1 mL of phosphate-buffered saline (PBS (−)), the cells were incubated with medium that did not contain FBS and in the presence of the MITO-Porter (pre-WT-tRNAPhe) (6.75 nM RNA [300 ng RNA]) for 3 h for direct mitochondrial transfection. MITO-Porter (RP-WT-tRNAPhe-MRP), MITO-Porter (tRK1-WT-tRNAPhe), or MITO-Porter (tRNAPhe (yeast)) were also added to the cells at similar way (6.75 nM RNA). For allotropic expression, pCMV-WT-tRNAPhe, pCMV-RP-WT-tRNAPhe-MRP, pCMV-tRK1-WT-tRNAPhe, or pCMV-WT-tRNAPhe (yeast) were transfected to cells using LFN 2000, according to the manufacturer’s recommended protocol (1 μg). After the incubation, the medium was replaced with complete medium containing FBS and further incubated at 37°C, 5% CO2, for 45 h or 93 h. After washing the cells with 1 mL PBS (−), they were treated with 500 μL of PBS (−) containing trypsin to remove cells. After incubation of the cells at 37°C, 5% CO2, for 3 min, 1 mL of complete medium was added to the cells, followed by centrifugation at 700 × g at 4°C for 3 min. The supernatant was removed to obtain the collected cells (step 2).
+ Open protocol
+ Expand
9

Chondrocyte Transcriptional Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at 1×105 cells/well in 6-well plates (Becton Dickinson Labware, Franklin Lakes, NJ, USA) and incubated for 7 days. After the cultured chondrocytes reached confluency, they were treated with 0 or 1 μg/mL of rhSDC4 with 0.1% bovine serum albumin. After exposure to SDC4 for 24 h, chondrocytes were collected, and mRNA was extracted. Total RNA was isolated using the RNeasy Plus Mini kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized using oligo(dT) 15 priming of 1 μg of total RNA, using a cDNA synthesis kit (Roche Diagnostics, Penzberg, Germany) according to the manufacturer’s protocol.
+ Open protocol
+ Expand
10

Radiosensitivity Evaluation via Colony Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
To investigate the radiosensitivity of the cells, we performed colony-formation assays. Briefly, 5 × 105 cells were seeded onto a T-25 flask (25 cm2, FALCON Becton Dickinson, Franklin Lakes, NJ) and were maintained at 37°C in a humidified atmosphere with 5% CO2 overnight. The next day, the medium was changed for fresh medium without FBS, and recombinant IL-6 was added 6 h later. After incubation for 24 h, the cells were irradiated with 6 Gy of γ-rays. The cells were trypsinized, and detached cells were collected and cultured in 6-well plates (Becton Dickinson), with an appropriate cell count depending on the survival rate (non-irradiated: 100, 6 Gy: 1000) for 10–12 days. After culturing, the plates were fixed with methanol and stained with 5% Giemsa solution. Colonies consisting of at least 50 cells were counted. The survival fraction was calculated from the plating efficiency.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!